---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-000056"
form_type: "8-K"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2024-01-02T23:59:59+00:00"
generated_at: "2026-06-07T05:25:03.027286+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Jasper Therapeutics announces 1-for-10 reverse stock split effective Jan 4, 2024

## Summary
- Reverse split ratio set at 1-for-10, effective 12:01 a.m. ET on Jan 4, 2024.
- Outstanding shares reduced from ~111.6M to ~11.2M; par value unchanged.
- Intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
- No fractional shares; cash in lieu based on Jan 3 closing price.
- Warrants adjusted: 10 warrants exercisable for 1 share at $115.00 per share.

## SEC filing metadata
- accession: 0001213900-24-000056
- form_type: 8-K
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2024-01-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390024000056/0001213900-24-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390024000056/ea190805-8k_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-000056
- JSON: https://secwatch.observer/filing/0001213900-24-000056.json
- Plain text: https://secwatch.observer/filing/0001213900-24-000056.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.